TRIFERTY-ATM®
Not Specified
Approved/CommercialCo-development completed
Key Facts
Indication
Not Specified
Phase
Approved/Commercial
Status
Co-development completed
Company
About Laboratorio Reig Jofre
Laboratorio Reig Jofre is a nearly century-old Spanish pharmaceutical company with a mission to universalize access to essential health solutions. It has evolved from a national player into an international organization with commercial and manufacturing operations across Europe and Asia, driven by a strategy of innovation, vertical integration in biotech manufacturing, and leveraging advanced technologies like its patented CicloTech® delivery system. The company is publicly listed on the Spanish stock exchange and is followed by several financial analysts, reflecting its established position in the market.
View full company profileTherapeutic Areas
Other Not Specified Drugs
| Drug | Company | Phase |
|---|---|---|
| Inflammation Programs | Arcus Biosciences | Not Specified |
| Bone Marrow Conditioning Program | Telix Pharmaceuticals | Pipeline |
| AGMB-447 | Agomab Therapeutics | Not Disclosed |
| AGMB-101 | Agomab Therapeutics | Not Disclosed |
| AGEN1571 (anti-ILT2) | Agenus | Not specified |
| AGEN1777 | Agenus | Not specified |
| AGEN1721 | Agenus | Not specified |
| INCAGN1876 (GITR Agonist) | Agenus | Not specified |
| INCAGN1949 (OX40 Agonist) | Agenus | Not specified |
| AGEN1327 (anti-TIGIT) | Agenus | Not specified |
| AGEN2373 (CD137 Agonist) | Agenus | Not specified |
| AGENT-797 (iNKT Cell Therapy) | Agenus | Not specified |